Risk signal mining of adverse events related to antibody-drug conjugates trastuzumab deruxtecan and trastuzumab emtansine: a study based on the US Food and Drug Administration Adverse Event Reporting System database
Tian Chunyu, Yang Shaojie, Fu Xian, Zhang Yanhua, Ma Xu, Zhao Bingqing
